Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK's NHS primary care gets £5.6bn spending for 2008-09:

This article was originally published in Clinica

Executive Summary

NHS primary care in England will have an extra £5.6bn ($11.4bn) to spend in 2008-09, with a 5.5% (£3.84bn) increase in recurrent revenue allocations and a £1.7bn non-recurrent budget announced yesterday by the Department of Health. These increases bring the annual primary care budget to £74.2bn - this is 82% of the total NHS revenue budget, up from 72% in 1996-97. The overall NHS budget is planned to rise to £110bn by 2010-11. Health minister Alan Johnson also unveiled the NHS Operating Framework for 2008-09, the key aims of which are: tighter hospital-acquired infection controls; better access to general practice services; achieving the 18-week referral-to-treatment target; and strengthening pandemic flu preparedness.

You may also be interested in...



Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials

Commission’s One-Year MDR Delay Text Contains EU-Wide Derogation Proposals Too

The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.

Australia Relaxes Competition Rules To Facilitate Coronavirus Response

Australia’s competition regulator, the ACCC, has granted a conditional dispensation to allow generics industry association the GBMA and brand body Medicines Australia to work together to help address the coronavirus pandemic by sharing information on stock, inventory, manufacturing and the supply chain. However, tender pricing will not be among the subjects discussed.

Topics

UsernamePublicRestriction

Register

MT050449

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel